000627Hubei Biocause Pharmaceutical000627 info
$0.41info-6.19%24h
Global rank5173
Market cap$2.01B
Change 7d-
YTD Performance1.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield9.5%
Main Sector
Financial Services
Business data

    Hubei Biocause Pharmaceutical (000627) Stock Overview

    Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.

    000627 Stock Information

    Symbol
    000627
    Address
    122-132 Yangwan RoadJingmen, 448000China
    Founded
    -
    Trading hours
    -
    Website
    https://www.biocause.com
    Country
    ๐Ÿ‡จ๐Ÿ‡ณ China
    Phone Number
    86 27 6565 1730

    Hubei Biocause Pharmaceutical (000627) Price Chart

    -
    Value:-

    Hubei Biocause Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.4067394466648777
    N/A
    Market Cap
    $2.01B
    N/A
    Shares Outstanding
    4.94B
    N/A
    Employees
    2.10K
    N/A
    Valuation
    2024
    Change
    P/FCF
    0.60
    N/A
    Dividends
    2024
    Change
    Dividend Yield
    9.53%
    N/A
    Dividend per share
    0.0388
    N/A
    Growth
    2024
    Change
    CAPEX
    -17.20M
    N/A
    Earnings
    2024
    Change
    Free Cash Flow
    $3.34B
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    ยฉ 2024 Topstocks.org